
BROKER MOVES: VRTX upgraded at Morgan Stanley, REGN downgraded; ORCL initiated at Wells Fargo
UPGRADES
- American Eagle (AEO) Upgraded to Neutral at JPMorgan; PT USD 20
- CSW Industrials (CSW) Upgraded to Overweight at JPMorgan; PT USD 350
- Design Therapeutics (DSGN) Upgraded to Outperform at Leerink; PT USD 14
- Driven Brands (DRVN) Upgraded to Outperform at William Blair
- Equinix (EQIX) Upgraded to Outperform at BMO; PT USD 900
- Garmin (GRMN) Upgraded to Buy at Longbow
- Lyft (LYFT) Upgraded to Neutral at Arete; PT USD 20
- PennantPark Investment (PNNT) Upgraded to Neutral at Compass Point
- Schneider National (SNDR) Upgraded to Outperform at Raymond James; PT USD 28
- Spruce Bio (SPRB) Upgraded to Outperform at Leerink; PT USD 160
- Uber (UBER) Upgraded to Buy at Arete; PT USD 125
- Vertex Pharmaceuticals (VRTX) Upgraded to Overweight at Morgan Stanley
DOWNGRADES
- Acadia Health (ACHC) Downgraded to Market Perform at Leerink; PT USD 14
- Applied Therapeutics (APLT) Downgraded to Market Perform at Leerink; PT USD 1
- Aurinia Pharmaceuticals (AUPH) Downgraded to Market Perform at Leerink; PT USD 16
- Biohaven (BHVN) Downgraded to Neutral at HC Wainwright; PT USD 11
- BioMarin (BMRN) Downgraded to Market Perform at Leerink; PT USD 60
- Charter Communications (CHTR) Downgraded to Strong Sell at CFRA
- Cognex (CGNX) Downgraded to Underweight at JPMorgan; PT USD 35
- InflaRx (IFRX) Downgraded to Market Perform at Leerink; PT USD 2
- Jamf Holding (JAMF) Downgraded to Market Perform at Citizens
- Pure Storage (PSTG) Downgraded to Neutral at Susquehanna; PT USD 100
- Regeneron (REGN) Downgraded to Equal-Weight at Morgan Stanley; PT USD 767
- Wayfair (W) Downgraded to Hold at Jefferies; PT USD 94
INITIATIONS
- Aardvark Therapeutics (AARD) Initiated at New Strong Buy at Raymond James
- Agilent (A) Initiated at New Overweight at Morgan Stanley; PT USD 180
- AppLovin (APP) Reinstated Buy at William O'Neil
- Bloom Energy (BE) Initiated at New Hold at Daiwa; PT USD 98
- Capri Holdings (CPRI) Reinstated Overweight at Barclays; PT USD 31
- CBL Properties (CBL) Initiated at New Buy at Ladenburg Thalmann; PT USD 45
- Compass Therapeutics (CMPX) Initiated at New Overweight at Cantor
- Compass Therapeutics (CMPX) Initiated at New Buy at Canaccord; PT USD 10
- Compass Therapeutics (CMPX) Initiated at New Market Outperform at Citizens
- D-Wave Quantum (QBTS) Initiated at New Outperform at Evercore ISI; PT USD 44
- Honeywell (HON) Initiated at New Neutral at BNPP Exane; PT USD 195
- Klarna (KLAR) Initiated at New Buy at President Capital Management; PT USD 39
- Lam Research (LRCX) Initiated at New Add at CTBC Securities; PT USD 175
- Linde (LIN) Initiated at New Outperform at CICC; PT USD 510
- Microbot Medical (MBOT) Reinstated Buy at Roth Capital Partners
- Oracle (ORCL) Initiated at New Overweight at Wells Fargo; PT USD 280
- Palatin Technologies (PTN) Initiated at New Buy at Lucid Capital Markets
- Pelthos Therapeutics (PTHS) Initiated at New Buy at HC Wainwright; PT USD 60
- Pitney Bowes (PBI) Initiated at New Market Outperform at Citizens; PT USD 13
- Theravance Bio (TBPH) Initiated at New Outperform at Oppenheimer; PT USD 27
- Traws Pharma Inc (TRAW) Initiated at New Buy at HC Wainwright; PT USD 8
- Viridian Therapeutics Inc (VRDN) Initiated at New Outperform at William Blair
- Wyndham Hotels (WH) Initiated at New Neutral at Mizuho Securities; PT USD 71
- Zymeworks (ZYME) Initiated at New Market Outperform at Citizens; PT USD 32
03 Dec 2025 - 12:19- Equities- Source: Newswires
Subscribe Now to Newsquawk
Click here for a 1 week free trial
Newsquawk provides audio news and commentary for over 15,000professional traders and brokers worldwide. Services include:
- Real-time audio coverage from 0630 to 2200 London time plus Asia-Pac 2200 to 1000 London time
- Teams of analysts covering equities, fixed income, FX, energy, and metals markets
- Real-time scrolling news service with instant analysis
- Daily and weekly pre-market research and calendars
- Video updates covering near-term key risk events & primary trading themes
- One-to-one chat with our expert analysts